- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06871865
The Effects of Oculomotor Training on Pain, Cervical Range of Motion, Joint Position Sense, Endurance, and Balance in Individuals With Mechanical Neck Pain
July 17, 2025 updated by: Eda AKBAŞ, Zonguldak Bulent Ecevit University
The aim of this study was to investigate the effects of oculomotor training on pain, cervical range of motion, joint position sense, endurance and balance in individuals with mechanical neck pain.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zonguldak, Turkey, 67100
- Zonguldak Bulent Ecevit University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosed with mechanical neck pain
- Neck pain lasting longer than 3 weeks
- Individuals aged 18-50 years
- Score of 5 or higher on the Neck Disability Index
Exclusion Criteria:
- Having received physical therapy in the last 6 months
- Presence of congenital anomaly on cervical radiography
- Neurological deficit detected in physical examination
- Diagnosis of vertebrobasilar artery insufficiency
- Diagnosis of vestibular disease
- Presence of a rheumatic disease
- Presence of structural scoliosis
- History of spinal surgery
- Pregnancy
- Malignancy
- Eye disease/strabismus other than refractive errors
- Active use of anti-inflammatory medication
- Any mental condition that may prevent adherence to exercises
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
This group will be given a home program including isometric neck strengthening exercises, neck stretching exercises and posture exercises during the 6-week treatment period, and the control group will be given an additional oculomotor exercise program.
|
Oculomotor exercises are designed to improve eye movement control, coordination, and visual tracking.
Postural exercises help strengthen core muscles, improve alignment, and enhance stability.
They are essential for maintaining proper posture, preventing pain, and reducing the risk of musculoskeletal imbalances.
Neck stretching and strengthening exercises help improve flexibility, reduce stiffness, and enhance muscle support for the cervical spine.
They are beneficial for relieving neck pain, improving posture, and preventing injuries.
|
|
Active Comparator: Control Group
This group will be given a home program including isometric neck strengthening exercises, neck stretching exercises and posture exercises during the 6-week treatment period.
|
Postural exercises help strengthen core muscles, improve alignment, and enhance stability.
They are essential for maintaining proper posture, preventing pain, and reducing the risk of musculoskeletal imbalances.
Neck stretching and strengthening exercises help improve flexibility, reduce stiffness, and enhance muscle support for the cervical spine.
They are beneficial for relieving neck pain, improving posture, and preventing injuries.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Visual Analog Scale
Time Frame: From enrollment to the end of treatment at 6 weeks
|
From enrollment to the end of treatment at 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neck Disability Index
Time Frame: From enrollment to the end of treatment at 6 weeks
|
From enrollment to the end of treatment at 6 weeks
|
|
|
Craniovertebral Angle
Time Frame: From enrollment to the end of treatment at 6 weeks
|
From enrollment to the end of treatment at 6 weeks
|
|
|
Cervical ROM
Time Frame: From enrollment to the end of treatment at 6 weeks
|
Flexion, extension, lert-right rotation, left-right lateral flexion will be measured.
|
From enrollment to the end of treatment at 6 weeks
|
|
Craniocervical Flexion Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
Endurance of the deep cervical flexor muscles will be measured.
|
From enrollment to the end of treatment at 6 weeks
|
|
Y Balance Test
Time Frame: From enrollment to the end of treatment at 6 weeks
|
Y Bavlance Test will be applied to test the ability to reach of upper extremity.
|
From enrollment to the end of treatment at 6 weeks
|
|
Beck Depression Inventory
Time Frame: From enrollment to the end of treatment at 6 weeks
|
From enrollment to the end of treatment at 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 3, 2025
Primary Completion (Actual)
June 5, 2025
Study Completion (Actual)
June 23, 2025
Study Registration Dates
First Submitted
March 7, 2025
First Submitted That Met QC Criteria
March 7, 2025
First Posted (Actual)
March 12, 2025
Study Record Updates
Last Update Posted (Actual)
July 18, 2025
Last Update Submitted That Met QC Criteria
July 17, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BEUN-AKBAS-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.